News By Tag
News By Place
The global pain management devices market will reach $3336.5m in 2014 according to new visiongain
LONDON, UK, 26th of June 2014: A new report by visiongain calculates that the global pain management devices market will reach $3336.5m in 2014 with revenues showing strong growth to 2024.
Moses Akintomide-Akinwamide, a pharmaceutical and medical technology market analyst at Visiongain comments: “As healthcare expenditure increases globally, two key areas pose great challenges to healthcare providers: chronic diseases and ageing populations. Pain management devices are playing an increasingly more significant role in the care of elderly patients. The tolerance and dependence issues which are notoriously associated with pain relieving drugs such as opioids, and the safety issues surrounding some non-steriodals such as Cox-2 inhibitors have led to market withdrawals in recent years. These withdrawals and their effects have left a gap in the industry for pain management devices to capitalise on. The desire of healthcare bodies to boost their patient satisfaction levels will also drive growth in this market over the coming decade.”
The positive side effect profiles of most pain management devices compared with pain relieving drugs such as opioids is a major growth driver. These therapeutic devices can be developed to be tailored to an individual patient’s needs. “Neurostimulatory devices, for instance, are already being personalised with stimulation programmed to change dependent on the patient’s posture. Large biotechnology companies have shown interest in this field, with companies such as Medtronic, and St Jude Medical already establishing and marketing multiple successful pain management devices”, Moses added.
The economically developed countries in North America and Europe dominated the pain management devices market in 2013. Globally, the rising incidence of chronic conditions will be a major driver for growth in the pain management devices market over the next decade. Huge strides have been taken to understand the neurobiology of pain; with patients increasingly gaining access to a variety of new approaches to diagnosing the cause of pain, as well as new strategies for managing their condition. All of these factors will contribute to increased domestic demand for pain management devices and ultimately contribute to the growth of the pain management devices market.
Visiongain’s 226 page report provides revenue forecasts to 2024 for the global pain management devices market and its leading national markets. It forecasts sales in the US, Japan, Germany, France, Italy, Spain, UK, China, India, Russia, Brazil, Mexico and South Korea. The report also forecasts sales for subsectors of the pain management devices market by device-type. These include spinal cord stimulation (SCS), microcurrent electrothermal neuromuscular stimulation (MENS), transcutaneous electrical nerve stimulation (TENS), radiofrequency ablation, intradiscal electrothermal therapy (IDET), and analgesia infusion pumps. .
Forecast and analysis for global pain management devices subsectors by application is also provided in the report. This includes devices used for the management of neuropathic pain, migraine & facial pain, cancer pain, surgical & trauma pain, and musculoskeletal pain. The report also includes two interviews with key opinion leaders in the industry sharing their views on current market trends and the unmet needs in the market.
Pain Management Devices Market Forecast 2014-2024: Future Prospects For Leading Companies adds to visiongain’s extensive range of analytical reports on industries and markets in healthcare.
For sample pages and further information concerning the visiongain report Pain Management Devices Market Forecast 2014-2024 : Future Prospects For Leading Companies please visit: https://www.visiongain.com/
For an executive summary please contact:
Email: Sara Peerun on sara.peerun@
Tel: +44 (0) 20 7336 6100
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. From its head office in London, UK, visiongain produces a range of newsletters, business reports and e-zines covering current affairs and market trends in the Energy, Telecoms, Pharmaceutical, Defence, and Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high quality, original analyses to inform their strategic decisions.